Mechanisms of Drug Resistance in Cancer Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms of Drug Resistance in Cancer Chemotherapy

Published:2005 Issue:1 Volume:14 Page:35-48
ISSN:1011-7571
Container-title:Medical Principles and Practice
language:en
Short-container-title:Med Princ Pract

Author:

Luqmani Y.A.

Publisher

S. Karger AG

Subject

General Medicine

Reference121 articles.

1. The ErbB/HER receptor protein-tyrosine kinases and cancer

2. Targeting the HER-kinase axis in cancer

3. Monoclonal antibody therapy for breast cancer: Herceptin

4. Review of epidermal growth factor receptor biology

Cited by 505 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of new nicotinamide derivatives generated via Suzuki Miyaura coupling as potential anticancer hits targeting pancreatic cancer cell line MIA PaCa-2;Journal of Molecular Structure;2024-12

2. Mitochondrial bioenergetics of breast cancer;Mitochondrion;2024-11

3. Research progress in tumor therapy of carrier-free nanodrug;Biomedicine & Pharmacotherapy;2024-09

4. Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy;Current Cancer Drug Targets;2024-08-27

5. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3